4.6 Article

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Hematology

Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations

Laura Rosinol et al.

Summary: This review identifies two types of soft-tissue involvement in multiple myeloma: EMD and PS. EMD disease is associated with high-risk cytogenetics, therapy resistance, and worse prognosis. For patients with PS involvement, a proteasome inhibitor-based regimen may be the best option.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Oncology

Extramedullary multiple myeloma

Manisha Bhutani et al.

LEUKEMIA (2020)

Article Oncology

Multiple myeloma: Every year a new standard?

S. Vincent Rajkumar

HEMATOLOGICAL ONCOLOGY (2019)

Article Surgery

Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma

Jarrod Buzalewski et al.

JOURNAL OF SURGICAL CASE REPORTS (2019)

Article Oncology

A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma

Juskaran Chadha et al.

CASE REPORTS IN ONCOLOGICAL MEDICINE (2019)

Article Medicine, General & Internal

Multiple myeloma

Shaji K. Kumar et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Article Hematology

How I treat extramedullary myeloma

Cyrille Touzeau et al.

Article Hematology

Cytogenetics of extramedullary manifestations in multiple myeloma

Lisa Billecke et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

Article Oncology

International uniform response criteria for multiple myeloma

B. G. M. Durie et al.

LEUKEMIA (2006)